in this issue

wrap up

The proud winners of our recent Willie Mays giveaway recap their grand prize trip to San Francisco.

from the editor

June and July have been very busy months in the diabetes world...

fingersticks

The magical world of the ADA Scientific Sessions.

The FDA hearings deciding the fate of type 2 diabetes drug Avandia and weight-loss drug Qnexa, Debiotech’s Android-compatible “JewelPUMP,” the OmniPod/DexCom integrated insulin pump/CGM, JDRF and sanofi-aventis’ partnership for cure-based research ,OneTouch’s new Delica Lancing System, JDRF’s new CEO Jeffrey Brewer, and Diamyd’s “vaccine” for type 1 diabetes.

thinking like a pancreas

The last word on the ultimate challenge in blood sugar control from a real expert – Gary Scheiner discusses how to best balance exercise and sports in diabetes management.

learning curve

Exciting findings from the largest diabetes meeting of the year, the American Diabetes Association’s annual Scientific Sessions.

diaTribe dialogue

Diabetes expert and former ADA President Dr. John Buse offers a take on the ADA and FDA and weighs in on the current regulatory environment and the impact of healthcare reform.

sum musings

Kerri Morrone Sparling reviews the 2nd annual Roche Social Media Summit – and the real change put into action as a result of the first Summit.

trial watch

Weight-loss surgery to resolve type 2 diabetes, an internet training program for teens with type 1 diabetes, and a couples-based intervention for type 2 diabetes.

in this issue

Issue 24